Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) and Cimatron Ltd. (NASDAQ:CIMT) Added to Growing Stock Report's NASDAQ Decliners Watch List

New York, NY -- (SBWIRE) -- 02/22/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) and Cimatron Ltd. (NASDAQ:CIMT)

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) a biopharmaceutical company that discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally closed down (-10.81%) on 2,200,224 shares traded following its fourth-quarter earnings report and announcement of a share offering. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) is currently down (-25.79%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)

Cimatron Ltd. (NASDAQ:CIMT) a company that designs, develops, manufactures, markets, and supports computer-aided design/computer aided manufacturing (CAD/CAM) software products closed down (-10.61) on 570,308 shares traded after Cimatron Limited's CEO Discusses Q4 2012 Results. Cimatron Ltd. (NASDAQ:CIMT) is currently down (-30.12%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Cimatron Ltd. (NASDAQ:CIMT)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com